In a non‐human primate MS model, the product of PARP1 enzymatic activity, PAR, was reported to be upregulated in scattered neurons near demyelinating plaques.[16] It remains enigmatic, however, whether PARP1 and its activity promote neuronal damage or enhance neuronal survival in the setting of MS and EAE. This evidence concerns the gene PARP1 and myeloid sarcoma.